CTRI/2013/08/003882招募中3 期
Phase III Randomised controlled trial comparing D2 versus D3 lymphadenectomy on outcomes of non-metastatic, resectable, but locally advanced, gastric cancer following neoadjuvant (perioperative) chemotherapy (ELANCe trial) - ELANCe
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 287
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ECOG performance status of 0 â?? 1 in patients deemed fit to undergo surgery at the pre-anaesthetic check
- •-Histologically proven gastric adenocarcinoma
- •-No evidence of distant metastases, or locally advanced inoperable disease, as evaluated by computed tomography, chest radiography, ultrasonography, and / or laparotomy
- •-Patient able to provide valid informed consent
- •-Patient completed at least 1 cycle of neoadjuvant chemotherapy
排除标准
- •Presence of any 1 of the following:
- •-Previous or concomitant other cancer
- •-Primary Oesophageal involvement extending to the stomach
- •-Distant hepatic / extrahepatic disease discovered on laparotomy
- •-Gross local disease in the porta precluding a curative resection
- •-Patient did not consent for the trial
研究者
相似试验
进行中（未招募）
1 期
Comparison of paclitaxel, liposomal doxorubicin (and, i.a. carboplatin) with epirubicin, paclitaxel and cyclophosphamide for neoadjuvant treatment of high-risk early breast cancerEUCTR2014-000619-14-DEGerman Breast Group
已完成
3 期
Study to find out if restricting raw fruits in patients with blood cancer can reduce infections.CTRI/2018/01/011418Cancer Institute200
已完成
3 期
Steroid tablets for preventing tiredness in cancer patients receiving chemotherapy medicine.CTRI/2018/08/015222Cancer Institute126
尚未招募
2 期
Randomized phase II/III trial comparing dose-dense Paclitaxel and Carboplatin (TC) therapy and conventional triweekly TC therapy for newly diagnosed or recurrent uterine carcinosarcomaJPRN-UMIN000025884Japanese Gynecologic Oncology Group400
进行中（未招募）
3 期
Randomized controlled trial of Primary Debulking Surgery (PDS) and Neoadjuvant Chemotherapy + Interval Debulking Surgery (NAC / IDS) in patients with stage IIIC / IV ovarian cancerOvarian cancer, Fallopian tube cancer, primary peritoneal cancerOvary, fallopian tube, peritoneumJPRN-jRCTs051190090Kato Kazuyoshi488